GW Pharmaceuticals Stock Soaring and Spurring on Bullish Calls
At the time of writing, GW Pharmaceuticals (NASDAQ:GWPH) stock is soaring nearly 15% and trading at $174.65 USD. At this current value, GWPH is trading at a six-month high, akin to pre-legalization prices when hype ... [Read]
GWPH Stock: JP Morgan Suggests a 32% Rise is on the Way
GWPH stock is up over 9.5% at the time of writing and selling for $109. But why the good turn? Well, GW Pharmaceuticals (NASDAQ:GWPH) has received a significant nod by JP Morgan Stanley (NYSE:JPM) today. ... [Read]
GWPH Stock: Watch Out for Epidiolex Sales to Dictate Performance
Since the latter half of September, GWPH stock has been on a downward trajectory. Adding insult to injury, it lost a further 10.5% in November, and December hasn't rewarded it much change either. Overall, the ... [Read]
GWPH Stock: Receives Favorable Results from Epidiolex Trials
GW Pharmaceuticals, the company behind the first FDA approved cannabis medicine Epidiolex, brought excitement to the market yesterday. It announced a successful trial of Epidiolex and further proved the medication's ability to treat two rare ... [Read]